MVCAX has more cash in the bank: 16.9B vs. LYRCX (1.3B). MVCAX pays higher dividends than LYRCX: MVCAX (1.08) vs LYRCX (0.00). LYRCX was incepted earlier than MVCAX: LYRCX (4 years) vs MVCAX (25 years). LYRCX (2.56) is less costly to investors than MVCAX (0.98). LYRCX is a more actively managed with annual turnover of: 32.00 vs. MVCAX (24.00). LYRCX (1000) and MVCAX (1000) have matching initial minimum investment requirements. LYRCX annual gain was more profitable for investors over the last year : 10.00 vs. MVCAX (7.94).

	LYRCX	MVCAX	LYRCX / MVCAX
Total Expense Ratio	1.99	0.97	205%
Annual Report Gross Expense Ratio	2.56	0.98	261%
Fund Existence	4 years	25 years	-
Gain YTD	14.352	13.701	105%
Front Load	N/A	6%	-
Min. Initial Investment	1000	1000	100%
Min. Initial Investment IRA	N/A	N/A	-
Net Assets	1.3B	16.9B	8%
Annual Yield % from dividends	0.00	1.08	-
Returns for 1 year	10.00	7.94	126%
Returns for 3 years	58.91	24.66	239%
Returns for 5 years	N/A	15.96	-
Returns for 10 years	N/A	81.68	-

View a ticker or compare two or three

Ask AI

Compare

Interact to see
Advertisement

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
MCEFX	12.88	N/A	N/A
BlackRock International Select Eq Inv C
VGHAX	87.78	N/A	N/A
Vanguard Health Care Adm
FTDZX	212.04	N/A	N/A
Franklin Biotechnology Discovery Adv
PMJPX	13.59	N/A	N/A
PIMCO RAE US Small I-2
CCGSX	29.21	N/A	N/A
Baird Chautauqua Global Growth Inv